A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease Subjects
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01171313 |
Recruitment Status :
Completed
First Posted : July 28, 2010
Last Update Posted : February 18, 2021
|
Sponsor:
XenoPort, Inc.
Information provided by (Responsible Party):
XenoPort, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | October 2011 |
Actual Study Completion Date : | December 2011 |
Certification/Extension First Submitted : | January 31, 2013 |